Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinoma

References

• Alexander FW. Micropathology of radiation reaction in the larynx. Ann Otol Rhinol Laryngol. 1963;72:831–841.
   PubMed Web of Science ®Google Scholar
• Mathes SJ, Alexander J. Radiation injury. Surg Oncol Clin N Am. 1996;5(4):809–824.
   PubMedGoogle Scholar
• Gibbs IC, Le QT, Shah RD, et al. Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers. Int J Radiat Oncol Biol Phys. 2003;57(2):489–494.
   PubMed Web of Science ®Google Scholar
• Debnam JM, Garden AS, Ginsberg LE. Benign ulceration as a manifestation of soft tissue radiation necrosis: imaging findings. AJNR Am J Neuroradiol. 2008;29(3):558–562.
   PubMed Web of Science ®Google Scholar
• Yan F, Ye Z, Wang F, et al. Clinical and imaging characteristics of 53 ulcers of post-radiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma. Mol Clin Oncol. 2016;5(4):351–356.
   PubMedGoogle Scholar
• Huang SH, O'Sullivan B, Su J, et al. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: the princess margaret experience and proposal. Cancer. 2020;126(15):3426–3437.
   PubMed Web of Science ®Google Scholar
• Shuryak I, Hall EJ, Brenner DJ. Optimized hypofractionation can markedly improve tumor control and decrease late effects for head and neck cancer. Int J Radiat Oncol Biol Phys. 2019;104(2):272–278.
   PubMed Web of Science ®Google Scholar
• Al-Mamgani A, Kwa SL, Tans L, et al. Single vocal cord irradiation: image guided intensity modulated hypofractionated radiation therapy for T1a glottic cancer: early clinical results. Int J Radiat Oncol Biol Phys. 2015;93(2):337–343.
   PubMed Web of Science ®Google Scholar
• Withers HR, Peters LJ, Taylor JM, et al. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys. 1995;33(3):563–568.
   PubMed Web of Science ®Google Scholar
• Vargo JA, Ferris RL, Clump DA, et al. Stereotactic body radiotherapy as primary treatment for elderly patients with medically inoperable head and neck cancer. Front Oncol. 2014;4:214.
   PubMedGoogle Scholar
• Baker S, Verduijn GM, Petit S, et al. Long-term outcomes following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma. Acta Oncol. 2019;58(6):926–933.
   PubMed Web of Science ®Google Scholar
• Al-Mamgani A, Tans L, Teguh DN, et al. Stereotactic body radiotherapy: a promising treatment option for the boost of oropharyngeal cancers not suitable for brachytherapy: a single-institutional experience. Int J Radiat Oncol Biol Phys. 2012;82(4):1494–1500.
   PubMed Web of Science ®Google Scholar
• Al-Mamgani A, Van Rooij P, Sewnaik A, et al. Brachytherapy or stereotactic body radiotherapy boost for early-stage oropharyngeal cancer: comparable outcomes of two different approaches. Oral Oncol. 2013;49(10):1018–1024.
   PubMed Web of Science ®Google Scholar
• Nguyen-Tan PF, Zhang Q, Ang KK, et al. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the radiation therapy oncology group 0129 trial: long-term report of efficacy and toxicity. J Clin Oncol. 2014;32(34):3858–3866.
   PubMed Web of Science ®Google Scholar
• Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35.
   PubMed Web of Science ®Google Scholar
• Selek U, Garden AS, Morrison WH, et al. Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys. 2004;59(3):743–751.
   PubMed Web of Science ®Google Scholar
• Denham JW, Peters LJ, Johansen J, et al. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol. 1999;52(2):157–164.
   PubMed Web of Science ®Google Scholar
• Joiner M, editor. Basic clinical radiobiology. 5th ed. Boca Raton (FL): CRC Press; 2019.
   Google Scholar
• Maciejewski B, Withers HR, Taylor JM, et al. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects. Int J Radiat Oncol Biol Phys. 1990;18(1):101–111.
   PubMed Web of Science ®Google Scholar
• Lee DS, Kim YS, Cheon JS, et al. Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment. Radiat Oncol. 2012;7(1):85.
   PubMed Web of Science ®Google Scholar
• Rasmussen JH, Håkansson K, Vogelius IR, et al. Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer. Radiother Oncol. 2016;120(1):76–80.
   PubMed Web of Science ®Google Scholar
• Olteanu LAM, Duprez F, De Neve W, et al. Late mucosal ulcers in dose-escalated adaptive dose-painting treatments for head-and-neck cancer. Acta Oncol. 2018;57(2):262–268.
   PubMed Web of Science ®Google Scholar
• Dörr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol. 2001;61(3):223–231.
   PubMed Web of Science ®Google Scholar
• Fei Z, Chen T, Qiu X, et al. Effect of relevant factors on radiation-induced nasopharyngeal ulcer in patients with primary nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Laryngoscope Investig Otolaryngol. 2020;5(2):228–234.
   PubMed Web of Science ®Google Scholar
• Maciejewski B, Skladowski K, Pilecki B, et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol. 1996;40(2):137–145.
   PubMed Web of Science ®Google Scholar
• Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983;41(5):283–288.
   PubMed Web of Science ®Google Scholar
• Silverstein P. Smoking and wound healing. Am J Med. 1992;93(1A):22S–24S.
   PubMed Web of Science ®Google Scholar
• Chen AM, Chen LM, Vaughan A, et al. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. Int J Radiat Oncol Biol Phys. 2011;79(2):414–419.
   PubMed Web of Science ®Google Scholar
• Zevallos JP, Mallen MJ, Lam CY, et al. Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer. 2009;115(19):4636–4644.
   PubMed Web of Science ®Google Scholar
• Ostroff JS, Jacobsen PB, Moadel AB, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995;75(2):569–576.
   PubMed Web of Science ®Google Scholar
• Chan Y, Irish JC, Wood SJ, et al. Smoking cessation in patients diagnosed with head and neck cancer. J Otolaryngol. 2004;33(2):75–81.
   PubMedGoogle Scholar
• Chen MY, Mai HQ, Sun R, et al. Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis. Chin J Cancer. 2013;32(10):533–538.
   PubMedGoogle Scholar
• Li Y, Xu T, Qian W, et al. Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: a dose-volume-outcome analysis. Oral Oncol. 2018;84:1–6.
   PubMed Web of Science ®Google Scholar